Skip to main content
Fig. 1 | Experimental Hematology & Oncology

Fig. 1

From: Elevated LDH greater than 400 U/L portends poorer overall survival in diffuse large B-cell lymphoma patients treated with CD19 CAR-T cell therapy in a real world multi-ethnic cohort

Fig. 1

LDH is an adverse prognostic variable in DLBCL patients receiving CAR T-cell therapy. A Correlation of LDH levels at the time of cell infusion and significance for difference in overall survival between the LDH cutoffs. A LDH cutoff level of 400 IU shows the highest difference in survival between patients. B Overall survival at LDH levels above and below 400 IU as shown by Kaplan Meier curves

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us